obagi nu-derm system normal-oily skin transformation trial

Generic: hydroquinone, homosalate, octisalate, zinc oxide

Labeler: obagi cosmeceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name obagi nu-derm system normal-oily skin transformation trial
Generic Name hydroquinone, homosalate, octisalate, zinc oxide
Labeler obagi cosmeceuticals llc
Dosage Form KIT
Manufacturer
Obagi Cosmeceuticals LLC

Identifiers & Regulatory

Product NDC 62032-914
Product ID 62032-914_bc389b46-a94e-4cc3-baec-73044c6a387f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2019-12-02

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62032914
Hyphenated Format 62032-914

Supplemental Identifiers

RxCUI
197795

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name obagi nu-derm system normal-oily skin transformation trial (source: ndc)
Generic Name hydroquinone, homosalate, octisalate, zinc oxide (source: ndc)

Resolved Composition

Strengths
  • 10 %
  • 5 %
  • 16.5 %
source: label
Packaging
  • 1 KIT in 1 KIT (62032-914-01) * 57 g in 1 BOTTLE, PLASTIC (62032-101-36) * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 TUBE (62032-140-05) * 59 mL in 1 BOTTLE, PLASTIC * 59 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

62032-914-01 1 KIT in 1 KIT (62032-914-01) * 57 g in 1 BOTTLE, PLASTIC (62032-101-36) * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 TUBE (62032-140-05) * 59 mL in 1 BOTTLE, PLASTIC * 59 mL in 1 BOTTLE, PLASTIC

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Obagi Nu-Derm System Normal-Oily Skin Transformation Trial ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "bc389b46-a94e-4cc3-baec-73044c6a387f", "openfda": {"rxcui": ["197795"], "spl_set_id": ["219c68dc-1e74-4136-9065-85466008d445"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 KIT (62032-914-01)  *  57 g in 1 BOTTLE, PLASTIC (62032-101-36)  *  28 g in 1 BOTTLE, PLASTIC *  28 g in 1 BOTTLE, PLASTIC *  28 g in 1 TUBE (62032-140-05)  *  59 mL in 1 BOTTLE, PLASTIC *  59 mL in 1 BOTTLE, PLASTIC", "package_ndc": "62032-914-01", "marketing_start_date": "20210625"}], "brand_name": "Obagi Nu-Derm System Normal-Oily Skin Transformation Trial", "product_id": "62032-914_bc389b46-a94e-4cc3-baec-73044c6a387f", "dosage_form": "KIT", "product_ndc": "62032-914", "generic_name": "Hydroquinone, Homosalate, Octisalate, Zinc Oxide", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Obagi Nu-Derm System Normal-Oily Skin Transformation Trial", "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20191202", "listing_expiration_date": "20261231"}